A research group in Korea has reported a higher prevalence of vitamin D deficiency in individuals with COPD.
The AARC has asked respiratory therapists in Texas to support an initiative that would establish a strategic plan for asthma and COPD.
Practice Fusion and AstraZeneca have announced a Population Health Management (PHM) program designed to aid healthcare professionals in their efforts to improve care for patients with asthma or COPD.
Individuals with COPD exacerbations requiring hospitalization were common and considered a predictor of reduced survival across all COPD stages, according to study results.
This ABC News article describes the differences between several types of cough and the potential reason behind them, including asthma, COPD and other conditions.
Scientists have found that regardless of their stage in life, lung cells are able to regenerate themselves in order to repair missing or damaged tissue.
Scientists have discovered a new isoform which could be involved both in the pathogenesis of pulmonary emphysema as well as in the failure of some therapy approaches.
In COPD, opioids can improve breathlessness, but not exercise capacity, according to a review published in the Annals of the American Thoracic Society.
Julie Nimoy, the daughter of actor Leonard Nimoy, and her fiancé David Knight are developing a film that will detail the latest therapies and treatments for COPD.
Lung diseases such as pulmonary fibrosis and emphysema are common in individuals with malfunctioning telomeres, and researchers from Johns Hopkins have discovered what occurs and why.
The ATS and ERS have published a statement describing the state of current evidence on the diagnosis, assessment, and management of COPD, including recommendations for future research.
LifeMap Solutions has launched a pilot program for COPD Navigator, an app that helps patients monitor and manage the symptoms of COPD.
GlaxoSmithKline has received approval from the Japanese Ministry of Health, Labour and Welfare for Encruse Ellipta to treat COPD. The drug has already been approved in the US and Canada under the trade name Incruse Ellipta.
Just over 24% of adults with COPD say they cannot work, compared to about 5% of adults in the general population, and 38% said they found it difficult to walk or climb stairs.
New research from the Washington University School of Medicine reveals insight into possibly counteracting inappropriate mucus production in conditions such as asthma and chronic obstructive pulmonary disease (COPD).
Repeated use of roflumilast increases the production of a protein that causes inflammation, which possibly results in COPD patients developing a tolerance to the drug.
AstraZenaca's investigational COPD drug PT003 hit its main goals in two late-stage trials, clearing the way for regulatory filings this year in the US and EU.
A new Respirology study has identified certain inflammatory markers that can be used to predict which COPD patients are at the highest risk of dying prematurely.
Mediware's Cardiac and Pulmonary Rehab solution helps support the CMS readmission reduction program, specifically related to COPD.
Patients with COPD and chronic bronchitis had a worse quality of life, symptoms and mental well-being than those patients with chronic airway obstruction, according to study results.